Analyst Price Targets — CDLX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 13, 2025 12:42 pm | — | Lake Street | $3.00 | $2.07 | TheFly | Cardlytics price target lowered to $3 from $5 at Lake Street |
| October 11, 2024 7:25 am | Mark Mahaney | Evercore ISI | $4.00 | $3.22 | TheFly | Cardlytics initiated with an In Line at Evercore ISI |
| August 16, 2024 8:46 am | Luke Horton | Northland Securities | $5.00 | $3.75 | TheFly | Cardlytics downgraded to Market Perform from Outperform at Northland |
| August 15, 2024 6:07 am | Omar Dessouky | Bank of America Securities | $3.50 | $3.69 | TheFly | Cardlytics downgraded to Underperform from Neutral at BofA |
| August 8, 2024 8:58 am | Jason Kreyer | Craig-Hallum | $4.00 | $2.96 | TheFly | Craig-Hallum downgrades Cardlytics to Hold following CEO news, Q3 guide |
| August 8, 2024 8:39 am | Luke Horton | Northland Securities | $7.00 | $6.90 | TheFly | Cardlytics price target lowered to $7 from $14 at Northland |
| June 18, 2024 7:50 am | Luke Horton | Northland Securities | $14.00 | $8.21 | StreetInsider | Northland Starts Cardlytics (CDLX) at Outperform |
| April 9, 2024 6:38 am | Kyle Peterson | Needham | $17.00 | $14.01 | StreetInsider | Cardlytics (CDLX) PT Raised to $17 at Needham |
| August 2, 2023 3:28 pm | Kyle Peterson | Needham | $19.00 | $13.48 | Benzinga | Cardlytics' Relationships With Top US Banks Is Key To Targeted Marketing Success: Analyst |
| November 2, 2022 1:39 pm | Kyle Peterson | Needham | $14.00 | $5.70 | Benzinga | Cardlytics Sees Price Target Cut By 26% To Reflect Macro Headwinds |
Latest News for CDLX
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the fourth quarter and full year ending December 31, 2025 will be released on March 4, 2026, after market close. Conference Call Details: When: March 4, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at…
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on January 12, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 1,000,000 restricted stock units of Cardlytics to its newly appointed Chief Financial Officer, David Evans. The restricted stock units were granted as a material inducement to employment with Cardlytics in accordance with Nasdaq…
Citizens Financial Group Inc. RI acquired a new position in Cardlytics, Inc. (NASDAQ: CDLX) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 518,663 shares of the company's stock, valued at approximately $1,260,000. Citizens Financial Group Inc. RI owned approximately 0.97%
Cardlytics, Inc. (NASDAQ: CDLX - Get Free Report) CFO Alexis Desieno sold 8,607 shares of the stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $1.17, for a total transaction of $10,070.19. Following the completion of the transaction, the chief financial officer directly owned 201,159 shares of the
Cardlytics (NASDAQ: CDLX - Get Free Report) and Datatec (OTCMKTS:DTTLY - Get Free Report) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Volatility and Risk Cardlytics has a beta of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for CDLX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.